Jove
Visualize
Contact Us

Related Experiment Videos

Atopic dermatitis: elements in clinical study design and analysis.

B B Abrams1

  • 1Dermatology Medical Research, Hoechst-Roussel Pharmaceuticals, Inc., Somerville, NJ 08876.

Acta Dermato-Venereologica. Supplementum
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification of skin diseases in nineteenth century America.

International journal of dermatology·1993
Same author

Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial.

Archives of dermatology·1992
Same author

Simplified experimental human dermatophytosis model.

International journal of dermatology·1992
Same author

Ciclopirox olamine: a hydroxypyridone antifungal agent.

Clinics in dermatology·1991
Same author

Caretakers of the skin and their therapies, 1700-1870. A time of transition in Northern Germany.

International journal of dermatology·1989
Same author

Relationship of large and small invertases in Saccharomyces: mutant selectively deficient in small invertase.

Journal of bacteriology·1978
Same journal

Atopic eczema - new insights in the definition, diagnostics and disease management. Proceedings of a LEO eczema workshop. November 2003. Copenhagen, Denmark.

Acta dermato-venereologica. Supplementum·2006
Same journal

Atopic hand eczema and treatment strategies.

Acta dermato-venereologica. Supplementum·2005
Same journal

Epidemiology and job-related problems for the eczema patient.

Acta dermato-venereologica. Supplementum·2005
Same journal

Treatment strategies and compliance for the adult patient with atopic eczema.

Acta dermato-venereologica. Supplementum·2005
Same journal

Compliance among patients with atopic eczema.

Acta dermato-venereologica. Supplementum·2005
Same journal

Contact allergic reactions in patients with atopic eczema.

Acta dermato-venereologica. Supplementum·2005
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Designing effective clinical trials for atopic dermatitis requires careful consideration of sample size, patient population, and data collection methods. These factors are crucial for ensuring the validity and reliability of trial results in understanding treatment effects.

Area of Science:

  • Dermatology
  • Clinical Research Methodology
  • Biostatistics

Background:

  • Clinical trials in atopic dermatitis (AD) are essential for evaluating treatment efficacy.
  • Statistical analysis of AD trials provides insights into probable treatment effects on average patients.
  • The interpretation of trial outcomes is influenced by design choices and potential biases.

Purpose of the Study:

  • To discuss critical considerations in the design and analysis of clinical trials for atopic dermatitis.
  • To provide practical suggestions for improving the quality and reliability of AD clinical studies.
  • To address factors affecting the validity of conclusions drawn from AD research.

Main Methods:

  • Review of key design elements in atopic dermatitis clinical trials.

Related Experiment Videos

  • Discussion of statistical analysis considerations for AD research.
  • Recommendations for optimizing data collection and management in AD studies.

    • Main Results:

    • The value of clinical trial conclusions is contingent upon investigator-controlled factors.
    • Factors such as sample size and patient heterogeneity significantly impact results.
    • Careful selection of measured parameters and bias mitigation are vital.

    Conclusions:

    • Rigorous design and analysis are paramount for robust atopic dermatitis clinical trials.
    • Specific suggestions are provided for inclusion/exclusion criteria, variable measurement, and scoring systems.
    • Improved study design enhances the reliability of findings on atopic dermatitis treatments.